Cargando…
Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity
Cx3cr1, the receptor for the chemokine Cx3cl1 (fractalkine), has been implicated in the progression and severity of Alzheimer’s disease-like pathology in mice, but the underlying mechanisms remain unclear. A complicating factor is that Cx3cr1 has been demonstrated in both neurons and microglia. Here...
Autores principales: | Dworzak, Jenny, Renvoisé, Benoît, Habchi, Johnny, Yates, Emma V., Combadière, Christophe, Knowles, Tuomas P., Dobson, Christopher M., Blackstone, Craig, Paulsen, Ole, Murphy, Philip M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454597/ https://www.ncbi.nlm.nih.gov/pubmed/26038823 http://dx.doi.org/10.1371/journal.pone.0127730 |
Ejemplares similares
-
A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021) -
Publisher Correction: A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021) -
Revising CX3CR1 Expression on Murine Classical and Non-classical Monocytes
por: Meghraoui-Kheddar, Aïda, et al.
Publicado: (2020) -
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
por: Limatola, Cristina, et al.
Publicado: (2014) -
CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration
por: Raoul, William, et al.
Publicado: (2010)